Spectrum Wealth Counsel »

Jazz Pharmaceuticals shares owned by Spectrum Wealth Counsel

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Spectrum Wealth Counsel from 13F filings

Historical chart of Spectrum Wealth Counsel investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Spectrum Wealth Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Spectrum Wealth Counsel

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.8k 15 123.20
2024-09-30 $1.7k 15 111.47

More positions owned by Spectrum Wealth Counsel

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr Technology (XLK)
Apple (AAPL)
First Tr Exchange-traded Ft Vest Ris (RDVI)
Microsoft Corporation (MSFT)
Ishares Tr Core Total Usd (IUSB)
Broadcom (AVGO)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Eli Lilly & Co Call Call Option (Principal) (LLY)
Ishares Tr Eafe Value Etf (EFV)
Meta Platforms Cl A (META)
TJX Companies (TJX)
JPMorgan Chase & Co. (JPM)
Ishares Tr Eafe Grwth Etf (EFG)

View all positions for Spectrum Wealth Counsel

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
LSV Asset Management
Pacer Advisors
Dimensional Fund Advisors
State Street Corporation
Capital World Investors
Ameriprise Financial
EcoR1 Capital
Jpmorgan Chase & Co
Camber Capital Management
Geode Capital Management
Polaris Capital Management
Swedbank AB
Renaissance Technologies

View all funds holding Jazz Pharmaceuticals